On Friday, SpringWorks Therapeutics Inc (NASDAQ: SWTX) was 3.17% up from the session before settling in for the closing price of $36.87. A 52-week range for SWTX has been $18.00 – $53.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -20.00% over the last five years. When this article was written, the company’s average yearly earnings per share was at 10.87%. With a float of $65.45 million, this company’s outstanding shares have now reached $73.49 million.
The firm has a total of 305 workers. Let’s measure their productivity.
SpringWorks Therapeutics Inc (SWTX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SpringWorks Therapeutics Inc stocks. The insider ownership of SpringWorks Therapeutics Inc is 11.66%, while institutional ownership is 98.78%. The most recent insider transaction that took place on Jun 03 ’24, was worth 1,955,113. In this transaction Chief Executive Officer of this company sold 49,000 shares at a rate of $39.90, taking the stock ownership to the 1,112,368 shares. Before that another transaction happened on Jun 03 ’24, when Company’s Chief Operating Officer sold 20,000 for $40.07, making the entire transaction worth $801,372. This insider now owns 249,600 shares in total.
SpringWorks Therapeutics Inc (SWTX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 3/31/2024, it has been observed that the corporation posted -1.25 earnings per share (EPS) during the time that was better than consensus figure (set at -1.26) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.87% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
You can see what SpringWorks Therapeutics Inc (SWTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 106.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.99, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -3.47 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Analysing the last 5-days average volume posted by the [SpringWorks Therapeutics Inc, SWTX], we can find that recorded value of 0.89 million was lower than the volume posted last year of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 24.61%. Additionally, its Average True Range was 2.03.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 15.35%, which indicates a significant decrease from 35.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.59% in the past 14 days, which was higher than the 47.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.44, while its 200-day Moving Average is $38.52. Now, the first resistance to watch is $38.90. This is followed by the second major resistance level at $39.75. The third major resistance level sits at $40.84. If the price goes on to break the first support level at $36.96, it is likely to go to the next support level at $35.87. Should the price break the second support level, the third support level stands at $35.02.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
There are 74,086K outstanding shares of the company, which has a market capitalization of 2.82 billion. As of now, sales total 5,450 K while income totals -325,100 K. Its latest quarter income was 21,010 K while its last quarter net income were -87,390 K.
